Invezz is an independent platform with the goal of helping users achieve financial freedom. In order to fund our work, we partner with advertisers who compensate us for users that Invezz refers to their services. While our reviews and assessments of each product on the site are independent and unbiased, brands may pay to appear higher up our table rankings or place ads in specific areas of the site. The order in which products and services appear on Invezz does not represent an endorsement from us, and please be aware that there may be other platforms available to you than the products and services that appear on our website. Read more about how we make money >
Recursion Pharmaceuticals Inc - Class A (NASDAQ:RXRX)
|Dividend Rate (ttm)||0.0000|
|Trading Day||Nov 26|
|Day's Range||18.01 - 19.23|
|52 Week Range||15.25 - 42.81|
Recursion Pharmaceuticals Inc - Class A dividends
Recursion Pharmaceuticals Inc - Class A has a market cap or net worth of $3.02 billion. The enterprise value is $0.
Recursion Pharmaceuticals Inc - Class A has 159.53 million shares outstanding.
The trailing PE ratio is 0.0000 and the forward PE ratio is -14.8911. Recursion Pharmaceuticals Inc - Class A's PEG ratio is 0.0000.
Stock Price Statistics
The stock price has decreased by -0.3994%. The beta is 0.0000, so Recursion Pharmaceuticals Inc - Class A's price volatility has been lower than the market average.
In the last 12 months, Recursion Pharmaceuticals Inc - Class A had revenue of $0 and earned $0 in profits. Earnings per share was $.
Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to its mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what Recursion believes is one of the world's largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that the company uses to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate its programs.
biotechnology company scaling more like a technology company..